US May Get Vaccines Soon! Experts Says Could Approve Before Phase-3 Trials Ends- Report 

Bringing hope and possibility for a novel coronavirus vaccine by 2020 end, the chief of the U.S. Food and Drug Administration said it could consider emergency authorisation to a vaccine before the completion of phase-3 human trials.

In an interview to The Financial Times newspaper in London, FDA commissioner Dr Stephen Hahn said "it was up to the vaccine developers to apply for approval before phase-3 trials were over. But in case, some developer did apply, FDA would consider it, and not reject it for not having completed phase-3 trials, which is the last and most comprehensive stage of testing of a vaccine. We may find that (application) appropriate. We may find that inappropriate. We will make a determination."

“This is going to be a science, medicine, data decision. This is not going to be a political decision,” he added. Further giving clarity on the usage, Hahn stated that if the emergency use authorisation was given, it would most likely be approved for use only in particularly vulnerable groups and not on everyone.

This big statement comes at a time when the Donald Trump administration wants to make a coronavirus vaccine available as early as possible. 

Even Trump himself has repeatedly said that he will introduce a vaccine in the US before the end of the year, most recently at the event to accept the Republican nomination for running for Presidency again.